Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,961 | -23,186 | -75,521 | -55,108 | -35,545 |
| Depreciation Amortization | -1,395 | -731 | -2,961 | -2,050 | -1,267 |
| Accounts payable and accrued liabilities | 1,783 | 835 | -164 | 880 | 2,894 |
| Other Working Capital | -2,815 | -3,956 | 9,798 | 6,525 | 5,027 |
| Other Operating Activity | 6,282 | 3,365 | 12,070 | 7,775 | 2,524 |
| Operating Cash Flow | $-44,106 | $-23,673 | $-56,778 | $-41,978 | $-26,367 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,833 | 8,833 | 12,018 | 6,306 | 19,404 |
| PPE Investments | N/A | N/A | -142 | -78 | -46 |
| Investing Cash Flow | $26,833 | $8,833 | $11,876 | $6,228 | $19,358 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,158 | 704 | 46,230 | 45,767 | 45,672 |
| Other Financing Activity | -307 | -233 | -234 | -234 | -159 |
| Financing Cash Flow | $24,851 | $471 | $45,996 | $45,533 | $45,513 |
| Beginning Cash Position | 23,491 | 23,491 | 22,397 | 22,397 | 22,397 |
| End Cash Position | 31,069 | 9,122 | 23,491 | 32,180 | 60,901 |
| Net Cash Flow | $7,578 | $-14,369 | $1,094 | $9,783 | $38,504 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,106 | -23,673 | -56,778 | -41,978 | -26,367 |
| Capital Expenditure | 0 | N/A | -142 | -78 | -46 |
| Free Cash Flow | -44,106 | -23,673 | -56,920 | -42,056 | -26,413 |